Investigation on regulation of N-acetyltransferase 2 expression by nuclear receptors in human hepatocytes
IntroductionArylamine N-acetyltransferase 2 (NAT2) expresses a well-defined genetic polymorphism in humans that modifies drug and xenobiotic metabolism. Recent studies and genome wide association studies have reported that genetic variants of NAT2 are associated with differential risks of developing...
Saved in:
Main Authors: | Kyung U. Hong, Anthony P. Aureliano, Kennedy M. Walls, David W. Hein |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1488367/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis
by: Rashmi Mahajan, et al.
Published: (2024-12-01) -
MYST2 histone acetyltransferase promotes lung adenocarcinoma progression by regulating the p38 MAPK signaling pathway
by: Zhiang Huang, et al.
Published: (2025-01-01) -
The Molecular Mechanism of Farnesoid X Receptor Alleviating Glucose Intolerance in Turbot (<i>Scophthalmus maximus</i>)
by: Gaochan Qin, et al.
Published: (2024-11-01) -
Progress on the role of N-acetyltransferase 10 in tumor development
by: GU Zhongjia, LAI Siying, CHEN Dunjin, DU Lili
Published: (2024-11-01) -
Exploring the role of N-acetyltransferases in diseases: a focus on N-acetyltransferase 9 in neurodegeneration
by: Prajakta Deshpande, et al.
Published: (2025-10-01)